|
ZDHHC13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.617670E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.100400E-02 |
| Normal-vs-Stage2 |
3.075600E-01 |
| Normal-vs-Stage3 |
1.426810E-04 |
| Normal-vs-Stage4 |
6.04129999999259E-05 |
| Stage1-vs-Stage2 |
3.146800E-01 |
| Stage1-vs-Stage3 |
1.451680E-02 |
| Stage1-vs-Stage4 |
9.059000E-03 |
| Stage2-vs-Stage3 |
2.384100E-02 |
| Stage2-vs-Stage4 |
1.300110E-02 |
| Stage3-vs-Stage4 |
6.826200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.444840E-03 |
| Normal-vs-AfricanAmerican |
4.795900E-02 |
| Normal-vs-Asian |
1.526000E-01 |
| Caucasian-vs-AfricanAmerican |
5.590400E-01 |
| Caucasian-vs-Asian |
6.877200E-01 |
| AfricanAmerican-vs-Asian |
5.934200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.178360E-03 |
| Normal-vs-Female |
6.460300E-03 |
| Male-vs-Female |
4.396000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.551600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.363100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.041800E-03 |
| Normal-vs-Age(81-100Yrs) |
4.244800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.354200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.865000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.622400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.795200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.093900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.529800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.010000E-01 |
| Normal-vs-Grade 2 |
1.282490E-02 |
| Normal-vs-Grade 3 |
4.153700E-04 |
| Normal-vs-Grade 4 |
9.33349999954203E-07 |
| Grade 1-vs-Grade 2 |
4.112600E-01 |
| Grade 1-vs-Grade 3 |
4.119800E-02 |
| Grade 1-vs-Grade 4 |
3.002900E-03 |
| Grade 2-vs-Grade 3 |
2.609600E-02 |
| Grade 2-vs-Grade 4 |
3.55419999999995E-05 |
| Grade 3-vs-Grade 4 |
4.623000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.475600E-03 |
| Normal-vs-ccB subtype |
4.436000E-02 |
| ccA subtype-vs-ccB subtype |
3.685800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.715600E-03 |
| Normal-vs-N1 |
3.222500E-03 |
| N0-vs-N1 |
3.212800E-01 |
|
|
